Sugi Predict

Sugi Predict / Compounds / SCHEMBL474124

SCHEMBL474124

SCHEMBL474124

CCCCCCCCCCCCC1CCN(CCCC)C1=O

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ GBA1 P04062 1/20 0.42
▸ CYP1A2 P05177 3/20 0.39
▸ ALDH1A1 P00352 1/20 0.38
▸ CHRNB2 P17787 1/20 0.37
▸ CHRNA7 P36544 1/20 0.37
▸ CHRNA4 P43681 1/20 0.37
▸ BCHE P06276 1/20 0.35
▸ ACE P12821 1/20 0.35
▸ S1PR1 P21453 1/20 0.35
▸ S1PR3 Q99500 1/20 0.35
▸ S1PR5 Q9H228 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ EPHX1 P07099 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ GNAI3 P08754 1/20 0.34
▸ GNAO1 P09471 1/20 0.34
▸ GNAI1 P63096 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6130819 0.97 GBA1 (0.45) GBA1CYP1A2ALDH1A1CHRNB2CHRNA7
SCHEMBL11775340 0.97 GBA1 (0.45) GBA1CYP1A2ALDH1A1CHRNB2CHRNA7
SCHEMBL3270939 0.97 GBA1 (0.45) GBA1CYP1A2ALDH1A1CHRNB2CHRNA7
SCHEMBL8602272 0.97 GBA1 (0.45) GBA1CYP1A2ALDH1A1CHRNB2CHRNA7
SCHEMBL9474303 0.97 GBA1 (0.45) GBA1CYP1A2ALDH1A1CHRNB2CHRNA7
SCHEMBL6535779 0.97 GBA1 (0.45) GBA1CYP1A2ALDH1A1CHRNB2CHRNA7
SCHEMBL28942756 0.95 GBA1 (0.44) GBA1CYP1A2ALDH1A1CHRNB2CHRNA7
SCHEMBL9568882 0.95 GBA1 (0.43) GBA1CYP1A2ALDH1A1CHRNB2CHRNA7
SCHEMBL3957901 0.93 CYP1A2 (0.39) GBA1CYP1A2ALDH1A1CHRNB2CHRNA7
SCHEMBL7759537 0.89 GBA1 (0.39) GBA1CYP1A2ALDH1A1CHRNB2CHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 168 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116370378-A Licorice root extract skin care product composition and preparation method thereof 广东诗漾医疗科技有限公司 2023-07-04 — — CN claimed
CN-109806243-B A skin external patch containing flupirtine or its medicinal salt 北京泰德制药股份有限公司 2022-07-15 — — CN claimed
CN-114588133-A An oxycodone-containing topical analgesic patch for skin and its preparation method 南方医科大学深圳医院 2022-06-07 — — CN claimed
US-10888533-B2 Transdermal composition containing donepezil as active ingredient ICURE PHARMACEUTICAL INC. (KR) 2021-01-12 — — US claimed
US-20190091168-A1 FORMULATION FOR ENHANCED TRANSDERMAL ABSORPTION OF DRUG UNIST(ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY) (KR) 2019-03-28 — — US claimed
EP-3235494-A1 TRANSDERMAL PREPARATION CONTAINING DONEPEZIL AS ACTIVE INGREDIENT Icure Pharmaceutical Inc. (KR) 2017-10-25 — — EP claimed
US-20170290780-A1 TRANSDERMAL COMPOSITION CONTAINING DONEPEZIL AS ACTIVE INGREDIENT ICURE PHARMACEUTICAL INC. (KR) 2017-10-12 — — US claimed
CN-106692111-A External skin patch containing ketoprofen and preparation method of external skin patch 北京泰德制药股份有限公司 2017-05-24 — — CN claimed
WO-2013056994-A1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS JAGOTEC AG (CH) 2013-04-25 — — WO claimed
WO-2013056993-A1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS JAGOTEC AG (CH) 2013-04-25 — — WO claimed
US-6673841-B2 TREATMENT OF ERECTILE DYSFUNCTION WHAN IN PHARM. CO., LTD. (KR) 2004-01-06 — — US claimed
US-20030125382-A1 Alprostadil alkyl ester-containing composition for external application WHAN IN PHARM. CO., LTD. 2003-07-03 — — US claimed
US-6500440-B1 PREPARATION COMPRISING ALPROSTADIL IN OILY VEHICLE WITH SKIN PERMEATION ENHANCER, ANTI-IRRITANT AGENT AND THICKENER WHAN IN PHARM CO., LTD. (KR) 2002-12-31 — — US claimed
US-6492180-B2 EXTRACTION THROUGH THE SKIN OR HAIR USING A 2-PYRROLIDONE IN A CARRIER; DRUGS OF ABUSE, CAFFEINE, PRESCRIPTION DRUGS, E.G. ACETAMINOPHEN, METABOLIC ANALYTES, E.G., BLOOD GLUCOSE AND HEAVY METALS, E.G. LEAD, LITHIUM, COPPER AND IRON TRANSDERM TECHNOLOGIES LLC 2002-12-10 — — US claimed
EP-1090301-B1 NON-INVASIVE TRANSDERMAL DETECTION OF ANALYTES TRANSDERM TECHNOLOGIES LLC (US) 2002-07-31 — — EP claimed
US-20020019055-A1 NON-INVASIVE TRANSDERMAL DETECTION OF ANALYTES TRANSDERM TECHNOLOGIES LLC 2002-02-14 — — US claimed
WO-2001097777-A1 TOPICAL PREPARATION OF ALPROSTADIL FOR THE TREATMENT OF ERECTILE DYSFUNCTION WHAN IN PHARM. CO. LTD. (KR) 2001-12-27 — — WO claimed
EP-1090301-A1 NON-INVASIVE TRANSDERMAL DETECTION OF ANALYTES Transderm Diagnostics, Inc. (US) 2001-04-11 — — EP claimed
WO-1999067645-A9 NON-INVASIVE TRANSDERMAL DETECTION OF ANALYTES TRANSDERM DIAGNOSTICS INC (US) 2000-03-16 — — WO claimed
WO-1999067645-A1 NON-INVASIVE TRANSDERMAL DETECTION OF ANALYTES TRANSDERM DIAGNOSTICS, INC. (US) 1999-12-29 — — WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190091168-A1 FORMULATION FOR ENHANCED TRANSDERMAL ABSORPTION OF DRUG APP, PSEN2, PSEN1 GBA1 3712/4885CYP1A2 46/4885ALDH1A1 1410/4885
US-10888533-B2 Transdermal composition containing donepezil as active ingredient PSEN1, ACHE, CUTA GBA1 3407/4885CYP1A2 674/4885ALDH1A1 3223/4885
US-20170290780-A1 TRANSDERMAL COMPOSITION CONTAINING DONEPEZIL AS ACTIVE INGREDIENT PSEN1, ACHE, CUTA GBA1 3407/4885CYP1A2 674/4885ALDH1A1 3223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.